Finance

Lists
BIM:EPA
BioMerieux SA
€77.20
-0.71%
(-0.55) 1D
Oct 1, 5:35:26 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for BIM...
Open
€77.55
High
€78.50
Low
€77.00
Mkt. cap
9.14B
Avg. vol.
158.84K
Volume
220.10K
P/E ratio
19.79
52-wk high
€116.70
52-wk low
€65.60
EPS
€3.90
Shares outstanding
118.36M
No. of employees
15K
Open
€77.55
High
€78.50
Low
€77.00
Mkt. cap
9.14B
Avg. vol.
158.84K
Volume
220.10K
P/E ratio
19.79
52-wk high
€116.70
52-wk low
€65.60
EPS
€3.90
Shares outstanding
118.36M
No. of employees
15K
News stories
From web sources and news partners
Profile
bioMérieux SA is a French multinational biotechnology company founded and headquartered in Marcy-l'Étoile, France, close to Lyon. bioMérieux is present in 44 countries and serves more than 160 countries through a large network of distributors. bioMérieux provides diagnostic solutions which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases, cancer screening, and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock exchange. Wikipedia
About BioMerieux SA
CEOPierre Boulud
Employees14.9K
Founded1963
HeadquartersMarcy-l'Étoile, Rhone-Alpes, France
SectorMedical device
Previous reports
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
11.67%
11.67%
11.51%
11.51%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps